Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/19/2025

Polycystic Ovary Syndrome (PCOS) Diagnosis and Management

Diagnosis Criteria

  • The Rotterdam Criteria for PCOS diagnosis require 2 of 3 criteria: oligo/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology, as recommended by the American College of Obstetricians and Gynecologists and the American College of Endocrinology 1, 2
  • PCOS is distinct from isolated polycystic ovaries, which can be found in 17-22% of women in the general population without the full syndrome, and requires exclusion of other relevant disorders, including Cushing's syndrome, androgen-secreting tumors, non-classic congenital adrenal hyperplasia, exogenous androgens, acromegaly, thyroid disorders, primary ovarian failure, and hyperprolactinemia 3, 2, 4
  • Characteristic ultrasound findings include >10 peripheral cysts, 2-8mm diameter, with thickened ovarian stroma, and the preferred approach for diagnosing PCOS is transvaginal ultrasound, if the patient is sexually active and it is acceptable to them 2, 3
  • The following table summarizes the diagnostic accuracy of different markers for PCOM:
Marker Sensitivity Specificity AUC
Follicle number per ovary (FNPO) 84% 91% 0.905
Ovarian volume 81% 81% 0.856

5

Diagnostic Evaluation

  • A comprehensive history evaluation, including onset and duration of hyperandrogenic symptoms, medication use, lifestyle factors, and distribution of body hair, is essential for diagnosing PCOS, along with physical examination for signs of hyperandrogenism and insulin resistance 4
  • First-line tests, including thyroid-stimulating hormone (TSH), prolactin, two-hour oral glucose tolerance test with 75g glucose load, and fasting lipid profile, are recommended to rule out other conditions and diagnose PCOS, as well as measurement of total testosterone (TT) and free testosterone (FT) using liquid chromatography with tandem mass spectrometry (LC-MS/MS) 4, 6
  • Mid-luteal phase progesterone levels <6 nmol/l indicate anovulation, and a fasting glucose/insulin ratio >4 suggests reduced insulin sensitivity 3

Management

  • The American College of Obstetricians and Gynecologists recommends lifestyle modifications as the first-line management for all women with PCOS, including a multicomponent approach with diet modifications, regular exercise, and behavioral strategies, with a focus on weight management for overweight/obese patients and healthy lifestyle behaviors for all patients 1
  • Consider lifestyle modifications, including diet, exercise, and behavioral strategies, as first-line treatment for all women with PCOS, focusing on weight management and healthy lifestyle behaviors, and treat PCOS by addressing hormonal imbalances, metabolic issues, and fertility concerns, which may include insulin-sensitizing agents like metformin, and hormonal treatments 1, 4
  • Screen for cardiovascular risk factors, including hypertension and dyslipidemia, as part of PCOS management, and address psychological factors, such as anxiety, depression, and eating disorders, which are prevalent in PCOS 7, 4

Complications and Screening

  • Patients with PCOS are at increased risk for type 2 diabetes, glucose intolerance, cardiovascular disease, endometrial cancer, and psychological disorders, including anxiety and depression, with an increased risk of endometrial cancer (OR 2.79) and ovarian cancer (OR 2.52) in women under 54 years, and should undergo screening, including glucose tolerance testing and lipid profiles 4, 3, 5, 8